JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Dairy Science Vol. 85 No. 6 1383-1389
© 2002 by American Dairy Science Association ®
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mullié, C.
Right arrow Articles by Romond, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mullié, C.
Right arrow Articles by Romond, C.

Partial Characterization of Bifidobacterium breve C50 Cell-free Whey Compounds Inducing Modifications to the Intestinal Microflora

C. Mullié 1, A. Yazourh 1, E. Singer 1, F. Lecroix 2, J.-P. Blareau 2, M. B. Romond 1, and C. Romond 1

1 Laboratoire de Bactériologie-Virologie, Faculté des Sciences Pharmaceutiques et Biologiques, 3, rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
2 Blédina SA, Rue Rémy Goetgheluck, 59114 Steenvoorde, France

Cell-free whey obtained from milk fermented with Bifidobacterium breve C50 (Bb C50) has been shown to modify the intestinal flora in humans and mice. Previous work showed that no antibiotic-like or barrier effect due to overgrowing bifidobacteria was implied in the microbial modifications. The present study was focused on characterizing the compounds and mechanisms involved. Protein, sugar, and enzymatic profiles of Bb C50 whey were therefore determined and compared to those of a whey unable to modify the intestinal flora of humans and mice. No remarkable difference was noted except for a higher lactosidase activity in Bb C50 whey. Various physical treatments were then applied to fractions of Bb C50 whey. Activity was assessed in C3H mice by analyzing changes in the intestinal flora balance throughout a 15-d administration of each treated whey. Heating at 80°C and aerobic storage for 2 wk completely abolished Bb C50 whey activities. In contrast, the addition of a reducing agent (cysteine hydrochloride), either at the beginning of a 15-d aerobic storage or prior to administration, as well as preserved these activities. Susceptibility to heating and oxidation suggested that an enzyme might play a role in the induced microbial changes. Since the Bb C50 lactosidase was partly inactivated by the oxidative treatment, it could support the in vivo activity. The enzyme might reach the intestinal lumen and partly degrade substrates, such as mucins, usually used by the intestinal flora. The released molecules might then favor the development of a new microbial balance.

Key Words: Bifidobacterium • milk fermentation products • lactosidase • glycoproteins

Submitted on June 20, 2001
Accepted on December 19, 2001






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Dairy Science Association ®.